ZA929529B - Pharmaceutical composition for the improvement of dysuria. - Google Patents

Pharmaceutical composition for the improvement of dysuria.

Info

Publication number
ZA929529B
ZA929529B ZA929529A ZA929529A ZA929529B ZA 929529 B ZA929529 B ZA 929529B ZA 929529 A ZA929529 A ZA 929529A ZA 929529 A ZA929529 A ZA 929529A ZA 929529 B ZA929529 B ZA 929529B
Authority
ZA
South Africa
Prior art keywords
denotes
carbon atoms
alkyl group
dysuria
group
Prior art date
Application number
ZA929529A
Other languages
English (en)
Inventor
Yuko Morioka
Mitsuru Takano
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of ZA929529B publication Critical patent/ZA929529B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA929529A 1991-12-10 1992-12-09 Pharmaceutical composition for the improvement of dysuria. ZA929529B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3325458A JP2549480B2 (ja) 1991-12-10 1991-12-10 排尿障害改善剤

Publications (1)

Publication Number Publication Date
ZA929529B true ZA929529B (en) 1993-06-15

Family

ID=18177097

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA929529A ZA929529B (en) 1991-12-10 1992-12-09 Pharmaceutical composition for the improvement of dysuria.

Country Status (18)

Country Link
US (1) US5496823A (ko)
EP (1) EP0546547B1 (ko)
JP (1) JP2549480B2 (ko)
KR (1) KR930012019A (ko)
CN (1) CN1073861A (ko)
AT (1) ATE110569T1 (ko)
AU (1) AU656443B2 (ko)
CA (1) CA2084962A1 (ko)
CZ (1) CZ282422B6 (ko)
DE (1) DE69200365T2 (ko)
DK (1) DK0546547T3 (ko)
ES (1) ES2062860T3 (ko)
HU (2) HUT63055A (ko)
IL (1) IL104026A (ko)
MX (1) MX9207123A (ko)
PH (1) PH30691A (ko)
TW (1) TW210286B (ko)
ZA (1) ZA929529B (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
DE19529102A1 (de) * 1995-08-08 1997-02-13 Kummer Horst Dieter Verwendung von PDE-Inhibitoren bei der Behandlung von Harnblasenerkrankungen
WO1998011888A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
WO2020186187A1 (en) * 2019-03-13 2020-09-17 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for treating bladder and urethra dysfunction and disease
WO2021065027A1 (ja) 2019-10-02 2021-04-08 あすか製薬株式会社 排尿障害改善剤
MX2022003983A (es) 2019-10-02 2022-04-26 Aska Pharm Co Ltd Agente mejorador de los trastornos de la miccion.
TW202241452A (zh) 2020-12-18 2022-11-01 日商Ａｓｋａ製藥股份有限公司 固形製劑

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2330742C2 (de) * 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
MX9207123A (es) 1993-07-30
CA2084962A1 (en) 1993-06-11
HUT63055A (en) 1993-07-28
ATE110569T1 (de) 1994-09-15
EP0546547B1 (en) 1994-08-31
AU656443B2 (en) 1995-02-02
JP2549480B2 (ja) 1996-10-30
TW210286B (ko) 1993-08-01
PH30691A (en) 1997-09-16
IL104026A (en) 1995-11-27
US5496823A (en) 1996-03-05
AU2998592A (en) 1993-06-17
DE69200365T2 (de) 1995-02-16
DE69200365D1 (de) 1994-10-06
DK0546547T3 (da) 1995-02-13
CZ282422B6 (cs) 1997-07-16
JPH05155773A (ja) 1993-06-22
KR930012019A (ko) 1993-07-20
HU9203911D0 (en) 1993-03-29
ES2062860T3 (es) 1994-12-16
CZ361192A3 (en) 1993-09-15
CN1073861A (zh) 1993-07-07
IL104026A0 (en) 1993-05-13
EP0546547A1 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
GR3029603T3 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing them.
IE890500L (en) 3-alkenyl-1-azabicyclo£3.2.0|hept-2-ene-2-carboxylic acid compounds
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
IE800327L (en) N-substituted aziridine-2-carboxylic acid derivatives
TW261616B (ko)
ES8200011A1 (es) Procedimiento de preparacion de una composicion farmaceuticaen particular psicotropa.
EP0682009A3 (en) Intermediate compounds for the preparation of endothelin receptor antagonist triterpene derivatives.
GR1002573B (el) Μικροβιακη μεθοδος παρασκευης μεβινολινης.
ZA929529B (en) Pharmaceutical composition for the improvement of dysuria.
CA2220024A1 (en) Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
AU1959192A (en) The use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
IL105558A0 (en) Therapeutic alcohols
IL110894A0 (en) Cephem derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
UA41880C2 (uk) Серотонінергічні похідні ерголіну і фармацевтична композиція
EP0014981A3 (en) Medicaments and pharmaceutical compositions with cytostatic activity
TW280810B (ko)
TW282470B (ko)
AU2224795A (en) Ameliorant or remedy for paraneoplastic syndrome